Riskpilot← Back to searchSign inGet full accessSTAVANGER HELSEFORSKNING AS
ASActiveOrg 986364080Jan Johnsens Gate 5, 4011 StavangerResearch and experimental development on social sciences and humanities · NACE 7220Est. 20031 employeeswww.stahf.no
Revenue 2024
NOK 4,4M
+20% vs 2023
EBITDA margin
-25.3%
-111% vs 2023
Equity ratio
4.6%
Financial strength
Net profit 2024
NOK -1,9M
-497% vs 2023
| Revenue | NOK 4,4M | +20% |
| EBITDA | NOK -1,1M | -111% |
| Net profit | NOK -1,9M | -497% |
| Total assets | NOK 117,9M | -18% |
| Equity | NOK 5,4M | -26% |
| Employees | 1 | — |
Legal name
STAVANGER HELSEFORSKNING AS
Org number
986364080
Legal form
Aksjeselskap
NACE code
7220 · Research and experimental development on social sciences and humanities
Founded
17. desember 2003
Share capital
NOK 500 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap
Company purpose
Koordinere og utvikle stavanger- regionens ulike fagmiljøer innenfor helserelatert forsking, samt delta i annen virksomhet i tilknytning til dette.
Address
Jan Johnsens Gate 5, 4011 Stavanger
Website
www.stahf.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 234 | 3 648 | 2 975 | 3 690 | 4 431 |
| Staff expenses | −1 723 | −1 702 | −851 | −269 | 215 |
| EBITDA | 152 | 38 | 157 | −532 | −1 122 |
| Depreciation & amort. | −30 | −15 | −0 | −0 | −0 |
| EBIT | 121 | 23 | 157 | −532 | −1 122 |
| Net financials | 1 250 | 1 889 | 436 | 952 | 542 |
| Profit before tax | 1 371 | 1 912 | 594 | 420 | −580 |
| Tax | 497 | 186 | 129 | −63 | 1 338 |
| Net profit | 875 | 1 726 | 465 | 483 | −1 918 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 114 330 | 127 534 | 143 484 | 143 831 | 117 922 |
| Equity | 4 678 | 6 404 | 6 869 | 7 352 | 5 434 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 109 653 | 121 130 | 136 615 | 136 480 | 112 489 |
| Total debt | 109 653 | 121 130 | 136 615 | 136 480 | 112 489 |
EBITDA margin
-25.3%
This company
15.8%
Market median
-260% vs market
20202024
Equity ratio
4.6%
This company
38.2%
Market median
-88% vs market
20202024
Return on equity
-35.3%
This company
18.4%
Market median
-292% vs market
20202024
Net profit margin
-43.3%
This company
8.1%
Market median
-635% vs market
20202024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202024
Debt / equity
20.70×
This company
0.62×
Market median
-3239% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
KJ Chief Executive Officer | Chief Executive Officer | 2021 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Deputy Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 48% | 48% | 2024 | |
| Company | 45% | 45% | 2024 | |
| Company | 7% | 7% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Universitetet I BergenNorce Norwegian Research Centre AsNorce Innovation As
STAVANGER HELSEFORSKNING AS (this company)Board members of STAVANGER HELSEFORSKNING AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristin Jonsdottir | Chief Executive Officer | 0 companies |
| Svein Skeie | Deputy Chairman | 0 companies |
| Susanne Cajsa Christina Gitlesen | Board of Directors | 0 companies |
| Tor Albert Ersdal | Board of Directors | 0 companies |
| Steinar Jørgensen | Board of Directors | 0 companies |
| Troels Gyde Jacobsen | Chairman | 0 companies |